
Awiqli: Weekly Insulin Launched in India
Novo Nordisk launches Awiqli, the world's first once-weekly basal insulin for diabetes, in India. This breakthrough injection simplifies management, offering improved control and convenience. Discover pricing, usage details, and how this innovation could transform daily diabetes care.









